Comparison

Neuroscience

581 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Domain II Biosimilar -­ Anti-­ERBB2 (Domain II);ERBB2 (Domain IV) mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1644-1MG

ProteoGenix
1 mg Login
Compare
Barecetamab Biosimilar -­ Anti-­ERBB3 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1646-100UG

ProteoGenix
100 ug Login
Compare
Barecetamab Biosimilar -­ Anti-­ERBB3 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1646-1MG

ProteoGenix
1 mg Login
Compare
Coprelotamab Biosimilar -­ Anti-­ERBB2 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1650-100UG

ProteoGenix
100 ug Login
Compare
Coprelotamab Biosimilar -­ Anti-­ERBB2 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1650-1MG

ProteoGenix
1 mg Login
Compare
Cudarolimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1651-100UG

ProteoGenix
100 ug Login
Compare
Cudarolimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1651-1MG

ProteoGenix
1 mg Login
Compare
Demupitamab Biosimilar -­ Anti-­EGFR mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1655-100UG

ProteoGenix
100 ug Login
Compare
Demupitamab Biosimilar -­ Anti-­EGFR mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1655-1MG

ProteoGenix
1 mg Login
Compare
Docaravimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­III mAb -­ Research Grade Antibody Primary Mu XtenCHO PX-TA1658-100UG

ProteoGenix
100 ug Login
Compare
Docaravimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­III mAb -­ Research Grade Antibody Primary Mu XtenCHO PX-TA1658-1MG

ProteoGenix
1 mg Login
Compare
Ebronucimab Biosimilar -­ Anti-­PCSK9 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1661-100UG

ProteoGenix
100 ug Login
Compare
Ebronucimab Biosimilar -­ Anti-­PCSK9 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1661-1MG

ProteoGenix
1 mg Login
Compare
Grisnilimab Biosimilar -­ Anti-­CD7 mAb -­ Research Grade Antibody Primary Mu XtenCHO PX-TA1672-100UG

ProteoGenix
100 ug Login
Compare
Grisnilimab Biosimilar -­ Anti-­CD7 mAb -­ Research Grade Antibody Primary Mu XtenCHO PX-TA1672-1MG

ProteoGenix
1 mg Login
Compare
Letaplimab Biosimilar -­ Anti-­CD47 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1678-100UG

ProteoGenix
100 ug Login
Compare
Letaplimab Biosimilar -­ Anti-­CD47 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1678-1MG

ProteoGenix
1 mg Login
Compare
Licaminlimab Biosimilar -­ Anti-­TNFA mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1679-100UG

ProteoGenix
100 ug Login
Compare
Licaminlimab Biosimilar -­ Anti-­TNFA mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1679-1MG

ProteoGenix
1 mg Login
Compare
Mipasetamab Biosimilar -­ Anti-­AXL mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1685-100UG

ProteoGenix
100 ug Login
Compare
Mipasetamab Biosimilar -­ Anti-­AXL mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1685-1MG

ProteoGenix
1 mg Login
Compare
Miromavimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­II mAb -­ Research Grade Antibody Primary Mu XtenCHO PX-TA1687-100UG

ProteoGenix
100 ug Login
Compare
Miromavimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­II mAb -­ Research Grade Antibody Primary Mu XtenCHO PX-TA1687-1MG

ProteoGenix
1 mg Login
Compare
Nadecnemab Biosimilar -­ Anti-­GFRA3 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1689-100UG

ProteoGenix
100 ug Login
Compare
Nadecnemab Biosimilar -­ Anti-­GFRA3 mAb -­ Research Grade Antibody Primary Other XtenCHO PX-TA1689-1MG

ProteoGenix
1 mg Login
Compare
Name Price
Domain II Biosimilar -­ Anti-­ERBB2 (Domain II);ERBB2 (Domain IV) mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Barecetamab Biosimilar -­ Anti-­ERBB3 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Barecetamab Biosimilar -­ Anti-­ERBB3 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Coprelotamab Biosimilar -­ Anti-­ERBB2 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Coprelotamab Biosimilar -­ Anti-­ERBB2 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Cudarolimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Cudarolimab Biosimilar -­ Anti-­TNFRSF4 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Demupitamab Biosimilar -­ Anti-­EGFR mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Demupitamab Biosimilar -­ Anti-­EGFR mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Docaravimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­III mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Mu
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Docaravimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­III mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Mu
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Ebronucimab Biosimilar -­ Anti-­PCSK9 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Ebronucimab Biosimilar -­ Anti-­PCSK9 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Grisnilimab Biosimilar -­ Anti-­CD7 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Mu
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Grisnilimab Biosimilar -­ Anti-­CD7 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Mu
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Letaplimab Biosimilar -­ Anti-­CD47 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Letaplimab Biosimilar -­ Anti-­CD47 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Licaminlimab Biosimilar -­ Anti-­TNFA mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Licaminlimab Biosimilar -­ Anti-­TNFA mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Mipasetamab Biosimilar -­ Anti-­AXL mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Mipasetamab Biosimilar -­ Anti-­AXL mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Miromavimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­II mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Mu
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Miromavimab Biosimilar -­ Anti-­Rabies Virus Strain ERA GP Ectodomain Epitope G-­II mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Mu
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available
Nadecnemab Biosimilar -­ Anti-­GFRA3 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 100 ug
Available
Nadecnemab Biosimilar -­ Anti-­GFRA3 mAb -­ Research Grade Login
Type Antibody Primary
Clone
Specific against Other
Appl.
Host XtenCHO
Item no.
Amount 1 mg
Available

581 Item(s)

per page